CompletedPHASE2, PHASE3NCT01776970

Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ospedale San Raffaele
Principal Investigator
Giancarlo Comi, MD
San Raffaele Scientific Institute
Intervention
Cannabis Sativa extract Oromucosal spray(drug)
Enrollment
60 enrolled
Eligibility
18-80 years · All sexes
Timeline
20132015

Study locations (4)

Collaborators

Fondazione Salvatore Maugeri · Niguarda Hospital · University of Padova

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01776970 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials